Status:
UNKNOWN
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Initially Node Positive Breast Cancer Patients, Could it Omit Axillary Dissection ?
Lead Sponsor:
Assiut University
Conditions:
Sentinel Lymph Node
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
The aim of this study is to determine the accuracy and safety of SLNB after neoadjuvant chemotherapy.
Detailed Description
Breast cancer is the most common cancer among women. The morbidity and mortality of breast cancer are much higher than those observed with other female cancers . The incidence of breast cancer increas...
Eligibility Criteria
Inclusion
- Female patients with operable breast cancer who had node-positive disease at presentation and pathological confirmation with either FNA or core biopsy
- Female Patient aged from 18 to 60 years old
- Patients who are fit for general anesthesia.
- Patient who agree to provide short term outcome data and agree to provide contact information to provide contact information.
Exclusion
- Stage 4 breast cancer
- Patient has no clinical response to NACT
- Patients who are contraindicated for radiotherapy
- Pregnant patients in first trimester
- Patient with inflammatory carcinoma
Key Trial Info
Start Date :
November 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06130241
Start Date
November 30 2023
End Date
April 1 2025
Last Update
November 14 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.